Bank Of Montreal Mirum Pharmaceuticals, Inc. Transaction History
Bank Of Montreal
- $192 Billion
- Q1 2025
A detailed history of Bank Of Montreal transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 56,340 shares of MIRM stock, worth $2.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,340
Previous 52,498
7.32%
Holding current value
$2.5 Million
Previous $2.17 Million
16.96%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding MIRM
# of Institutions
224Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$301 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$211 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$143 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$124 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$113 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.63B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...